NIH panel releases COVID-19 treatment guidelines

A panel of experts convened by the National Institutes of Health today released COVID-19 treatment guidelines for health care providers, which will be updated as new data become available.
Based on preliminary and published data, the guidelines include recommendations for two categories of therapy currently under investigation: antivirals, such as chloroquine and remdesivir; and host modifiers/immune-based therapies, such as convalescent plasma.
Each recommendation includes a rating for strength of recommendation and for quality of evidence supporting the recommendation. They also include guidance on caring for critically ill patients and using concomitant medications for treatment, such as statins and corticosteroids